Superworth

Cerenome EPS CNSY

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$4.36
Latest quarter, Q2 FY26
−$1.31
Fiscal year 2025
−$32.02

Cerenome's earnings per share was −$4.36 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.31.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$32.02n/a
FY2024−$40.50n/a
FY2023−$112.75n/a
FY2022−$294.75n/a
FY2021−$423.75n/a
FY2020−$671.25n/a
FY2019−$11021.25n/a
FY2018−$695212.50n/a
FY2017−$7928812.50n/a
FY2016−$12311250.00n/a
FY2015−$26551875.00n/a
FY2014−$67528125.00n/a
FY2013−$52368750.00n/a
FY2012−$74418750.00n/a
FY2011−$82687500.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.31n/a−$4.36
Q1 FY26−$1.05n/a−$3.21
Q4 FY25−$1.00−119%−$32.02
Q3 FY25−$1.00n/a−$25.77
Q2 FY25−$0.16n/a−$34.02
Q1 FY25−$29.86n/a−$51.61
Q4 FY24$5.25n/a−$40.50
Q3 FY24−$9.25n/a−$67.00
Q2 FY24−$17.75n/a−$82.75
Q1 FY24−$18.75n/a−$79.75
Q4 FY23−$21.25n/a−$112.75
Q3 FY23−$25.00n/a−$154.75

Against its peers

Companies in Medical - Instruments & Supplies nearest Cerenome's size, closest first, today.

CompanyEPS, 12 monthsGrowth
CNSYCerenome−$4.36
NEPHNephros$0.16+33% a year
APTAlpha Pro Tech$0.41+24% a year
KEQUKewaunee Scientific$2.76−33% a year
Peer median$0.41

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Cerenome

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.